Together we will beat cancer

Donate

Cancer Research UK spin-out gets US approval to trial unique T cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.  

Read More

Ground-breaking trial pilots new tests to detect lung cancer earlier

The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable.

Read More

Combination immunotherapy for advanced bowel cancer approved for NHS in England

People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England.

Read More

Let’s talk about HPV: 6 common questions answered

We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses.

Read More

Fears breast cancer progress could stall due to COVID-19 backlog

Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow.

Read More

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

Read More

New hormone treatment for advanced prostate cancer made available in England

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.

Read More

Scientists find cells in centre of tumours are most likely to spread

The new findings shed light on how cancer cells found in different parts of a tumour behave differently.

Read More

Research shows one size doesn’t fit all for cervical screening in the trans and non-binary community

Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening.

Read More

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

Read More